January 23, 2025 Trump’s AI Revolution: Stargate Initiative Sparks Economic Surge
January 21, 2025 Trump’s Inauguration: Crypto Soars, Tariffs Threaten Global Trade
January 20, 2025 Economic Shifts: Chicago Fed, Tech Scrutiny, and Labor Strikes
January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
Amazon: Evaluating AWS Growth Amid Shifting Competitive Landscape
Apple: Evaluating Growth Catalysts Amid Changing Fundamentals
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
GlaxoSmithKline (GSK) stock forecast for 2025
Updated: January 23, 2025 (22:26)
Sector: HealthcareThe share price of GlaxoSmithKline plc (GSK) now
50/200 Day Moving Average: $34.1 / $39.2
This figure corresponds to the Average Price over the previous 50/200 days. For GlaxoSmithKline stocks, the 50-day moving average is the resistance level today.
For GlaxoSmithKline stocks, the 200-day moving average is the resistance level today.
Are you interested in GlaxoSmithKline plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GlaxoSmithKline stock price in 2025. How much will one GlaxoSmithKline share be worth in 2025? Is it worth taking profit / loss on GSK stock now or waiting? What are analysts' forecasts for GlaxoSmithKline stock?
We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GSK stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
GlaxoSmithKline plc stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for GlaxoSmithKline analysts is $44.22. Today 200 Day Moving Average is the resistance level (39.2 $). 50 Day Moving Average is the resistance level (34.1 $).
Historical and forecast chart of GlaxoSmithKline plc stock
The chart below shows the historical price of GlaxoSmithKline stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GSK stock price can be found in the table below.
GlaxoSmithKline plc is engaged in the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, OTC drugs and health-related consumer products in the United Kingdom, the United States and internationally. It operates in four segments: pharmaceuticals, pharmaceutical research and development, vaccines and consumer healthcare. The company offers pharmaceutical products that include drugs in therapeutic areas such as respiratory, HIV, immunoinflammatory, cancer, antiviral, central nervous system, cardiovascular and urogenital, metabolic, antibacterial and dermatological. It also provides consumer healthcare products in the categories of health, oral health, nutrition, and skin health. The company offers its consumers medical products in the form of nasal sprays, tablets, syrups, lozenges, chewing gums and transdermal patches, drops, drops of baby syrup, liquid suspension, wipes, gels, effervescent substances, toothpastes, toothbrushes, mouth rinses, adhesives for dentures and detergents, topical creams and non-drug plasters, lip balms, chewing gums and soft chewing gums. She has cooperation agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics specializing in immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, UK.
GlaxoSmithKline (GSK) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb | 32.94 | 32.64 | 33.24 | 1.81 % |
| Mar | 32.78 | 32.40 | 33.37 | 2.92 % |
| Apr | 32.96 | 32.59 | 33.21 | 1.88 % |
| May | 33.38 | 32.59 | 33.65 | 3.15 % |
| Jun | 32.96 | 32.66 | 33.44 | 2.34 % |
| Jul | 33.66 | 32.92 | 33.97 | 3.09 % |
| Aug | 33.24 | 32.91 | 33.84 | 2.74 % |
| Sep | 32.93 | 32.63 | 33.19 | 1.67 % |
| Oct | 33.17 | 32.42 | 33.52 | 3.27 % |
| Nov | 32.91 | 32.45 | 33.29 | 2.55 % |
| Dec | 33.20 | 33.00 | 33.95 | 2.82 % |
GlaxoSmithKline information and performance
980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB
Market capitalization of the GlaxoSmithKline plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GSK shares in the company outstanding by the market price of one share.
EBITDA of GlaxoSmithKline is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
GlaxoSmithKline price target for 2025 by month
Target values for the price of one GlaxoSmithKline share for Feb 2025.
In Feb, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 1.813% volatility is expected.
Pessimistic target level: 32.64
Optimistic target level: 33.24
Target values for the price of one GlaxoSmithKline share for Mar 2025.
In Mar, the Negative dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 2.918% volatility is expected.
Pessimistic target level: 32.40
Optimistic target level: 33.37
Target values for the price of one GlaxoSmithKline share for Apr 2025.
In Apr, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 1.875% volatility is expected.
Pessimistic target level: 32.59
Optimistic target level: 33.21
Target values for the price of one GlaxoSmithKline share for May 2025.
In May, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 3.154% volatility is expected.
Pessimistic target level: 32.59
Optimistic target level: 33.65
Target values for the price of one GlaxoSmithKline share for Jun 2025.
In Jun, the Negative dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 2.336% volatility is expected.
Pessimistic target level: 32.66
Optimistic target level: 33.44
Target values for the price of one GlaxoSmithKline share for Jul 2025.
In Jul, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 3.092% volatility is expected.
Pessimistic target level: 32.92
Optimistic target level: 33.97
Target values for the price of one GlaxoSmithKline share for Aug 2025.
In Aug, the Negative dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 2.741% volatility is expected.
Pessimistic target level: 32.91
Optimistic target level: 33.84
Target values for the price of one GlaxoSmithKline share for Sep 2025.
In Sep, the Negative dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 1.667% volatility is expected.
Pessimistic target level: 32.63
Optimistic target level: 33.19
Target values for the price of one GlaxoSmithKline share for Oct 2025.
In Oct, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 3.266% volatility is expected.
Pessimistic target level: 32.42
Optimistic target level: 33.52
Target values for the price of one GlaxoSmithKline share for Nov 2025.
In Nov, the Negative dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 2.550% volatility is expected.
Pessimistic target level: 32.45
Optimistic target level: 33.29
Target values for the price of one GlaxoSmithKline share for Dec 2025.
In Dec, the Positive dynamics for GlaxoSmithKline plc shares will prevail with possible monthly volatility of 2.816% volatility is expected.
Pessimistic target level: 33.00
Optimistic target level: 33.95
GlaxoSmithKline (GSK) stock dividend
GlaxoSmithKline last paid dividends on 11/15/2024. The next scheduled payment will be on 01/09/2025. The amount of dividends is $0.61 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
